10-K/A XBRL

10-K/A

Company: ATOSSA THERAPEUTICS, INC.
Filed: March 21, 2017
Period of Report: December 31, 2016
Accession Number: 0001615774-17-001151

View Document ↗ View on SEC.gov ↗